July 2009

Friday, July 31, 2009

Philadelphia-based eResearch Technology (ERT) reported second quarter financial results after the markets closed Thursday. Included in the results were ERT’s electronic data capture (EDC) operations, which were sold to Omnicomm Systems in June.

Wednesday, July 29, 2009

Covance reported an increase in both early- and late-stage drug development revenues for the second quarter of 2009 compared with the first quarter, but early-stage revenues remain significantly lower than the same period last year.

Tuesday, July 28, 2009

Within days of announcing the pending acquisition of Covance’s interactive voice and web response business, eClinical company Phase Forward announced Monday it has purchased technology company Maaguzi for $11 million cash.

Tuesday, July 28, 2009

A new report released last week by the Association of Clinical Research Organizations (ACRO) says clinical trials conducted in the developing world not only match the quality and safety standards of those conducted in the developed world but they also improve the global drug development process.

Thursday, July 23, 2009

Dublin, Ireland-based ICON gave shareholders a triple dose of good news yesterday with its second quarter 2009 earnings release. Revenues, income and earnings per share were all up compared to last year. Net revenues increased $1.7 million to $220 million and net income jumped $4 million to $22.8 million or 38 cents per share on a diluted basis.

Wednesday, July 22, 2009

Wilmington, N.C.-based PPD’s second quarter revenues fell nearly $50 million to $355.2 million, but its earnings per share were boosted by the sale of its subsidiary, Piedmont Research Center, which was part of the company’s discovery sciences segment.

Friday, July 17, 2009

Chiltern International reported a 44% revenue increase for the year ended March 31, 2009, due in large part to acquisitions. The UK-based CRO attributed 15% of its growth to acquisitions, including the recent acquisition of Brazil CRO Vigiun.